Nama Insights

F/m Emerald Life Sciences Innovation ETF (LFSC)

Health · Emerald Mutual Fund Advisers Trust · NASDAQ

HealthETF
F/m Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund in the Health category. It has $123.35M in assets, an expense ratio of 0.54% and a 0.00% dividend yield. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Assets under management$123.35M
Expense ratio0.54%
CategoryHealth
Dividend yield0.00%
NAV$43.63
Fund familyEmerald Mutual Fund Advisers Trust
ExchangeNASDAQ

Top holdings

The largest positions F/m Emerald Life Sciences Innovation ETF reports, by weight.

HoldingNameWeight
CORT Corcept Therapeutics Inc 7.05%
TVTX Travere Therapeutics Inc Ordinary Shares 6.69%
LIVN LivaNova PLC 6.54%
COGT Cogent Biosciences Inc 6.11%
SYRE Spyre Therapeutics Inc 5.16%
BLLN BillionToOne Inc Ordinary Shares - Class A 4.67%
GH Guardant Health Inc 4.41%
REPL Replimune Group Inc 4.38%
MANE Veradermics Inc 3.64%
MIRM Mirum Pharmaceuticals Inc 3.44%

Other Health ETFs

Explore live LFSC data on Nama Insights →